TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes

NCT05462457 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kliniken Essen-Mitte